FK463
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Aspergillosis
Conditions
Aspergillosis
Trial Timeline
Jan 29, 1999 → Jan 31, 2002
NCT ID
NCT00036166About FK463
FK463 is a phase 2 stage product being developed by Astellas Pharma for Aspergillosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00036166. Target conditions include Aspergillosis.
What happened to similar drugs?
8 of 16 similar drugs in Aspergillosis were approved
Approved (8) Terminated (6) Active (6)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00036179 | Phase 2 | Completed |
| NCT00036166 | Phase 2 | Completed |
Competing Products
20 competing products in Aspergillosis